DK111488B - Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf. - Google Patents

Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf.

Info

Publication number
DK111488B
DK111488B DK453866A DK453866A DK111488B DK 111488 B DK111488 B DK 111488B DK 453866 A DK453866 A DK 453866A DK 453866 A DK453866 A DK 453866A DK 111488 B DK111488 B DK 111488B
Authority
DK
Denmark
Prior art keywords
hydroxy
salts
amino
preparation
acetic acid
Prior art date
Application number
DK453866A
Other languages
English (en)
Inventor
J Ag Geigy
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of DK111488B publication Critical patent/DK111488B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK453866A 1965-04-15 1966-09-02 Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf. DK111488B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530965A CH454147A (de) 1965-04-15 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
DK111488B true DK111488B (da) 1968-09-02

Family

ID=4291422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453866A DK111488B (da) 1965-04-15 1966-09-02 Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf.

Country Status (3)

Country Link
AT (1) AT253505B (da)
CH (1) CH454147A (da)
DK (1) DK111488B (da)

Also Published As

Publication number Publication date
CH454147A (de) 1968-04-15
AT253505B (de) 1967-04-10

Similar Documents

Publication Publication Date Title
DK119153B (da) Analogifremgangsmåde til fremstilling af 3-benzoyl-phenyleddikesyre-derivater eller salte deraf.
DK112531B (da) Fremgangsmåde til fremstilling af basisk substituerede phthalaner eller iso-chromaner eller syreadditionssalte deraf.
DK118133B (da) Fremgangsmåde til fremstilling af α-carboxy-6-aminopenicillansyrederivater eller salte deraf.
DK121365B (da) Analogifremgangsmåde til fremstilling af 4-chlor-5-sulfamylsalicylsyrederivater eller salte deraf.
DK117639B (da) Fremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller salte deraf.
DK115111B (da) Fremgangsmåde til fremstilling af 2-anilinonikotinsyrederivater eller salte heraf.
DK125461B (da) Fremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller salte deraf.
DK118457B (da) Analogifremgangsmåde til fremstilling af bis-guanylhydrazoner af diphenylurinstoffer eller salte deraf.
DK117427B (da) Fremgangsmåde til fremstilling af phenoxypropanolaminer eller syreadditionssalte deraf.
DK119059B (da) Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf.
DK112308B (da) Fremgangsmåde til fremstilling af 4- eller 5-aryl-1-naphthaleneddikesyrer eller salte deraf.
DK115767B (da) Fremgangsmåde til fremstilling af 2-phenoxy-2-alkylideneddikesyrer eller salte deraf.
DK129924B (da) Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf.
DK134859B (da) Fremgangsmåde til fremstilling af 7-acylamido-3-pyridinomethyl-3-cephem-4-carboxylsyrer eller additionssalte deraf.
DK118666B (da) Fremgangsmåde til fremstilling af 3-amino-4-carboxamidopyrazol eller salte deraf.
DK120159B (da) Analogifremgangsmåde til fremstilling af p-alkyloxy-, p-alkenyloxy-, p-alkynyloxy- eller p-cycloalkenyloxyfenyleddikesyrer eller salte deraf.
DK107095C (da) Fremgangsmåde til fremstilling af azcycloalkanderivater eller salte deraf.
DK115840B (da) Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf.
DK121086B (da) Analogifremgangsmåde til fremstilling af aminoalkanoylbenzofurancarboxylsyrer eller salte deraf.
DK112528B (da) Fremgangsmåde til fremstilling af tropanyl-2-phenylacrylatderivater eller salte deraf.
DK131679B (da) Analogifremgangsmåde til fremstilling af 6-aminopenicillansyrederivater eller salte deraf.
DK112030B (da) Fremgangsmåde til fremstilling af 3-amino-1-adamantancarboxylsyre eller salte deraf.
DK128650B (da) Analogifremgangsmåde til fremstilling af N-propionyl-ε-aminocapronsyre eller salte heraf.
DK123521B (da) Analogifremgangsmåde til fremstilling af 3-(α-hydroxypentyl)-4-hydroxybenzoesyre eller estere eller salte deraf.
DK111488B (da) Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf.